期刊文献+

6个上市的小分子海洋药物的全合成方法 被引量:6

The total synthesis method of six small molecular marine drugs
原文传递
导出
摘要 骨架新颖、活性独特的海洋天然产物是药物先导化合物的重要来源,但由于海洋样品采集困难、一些高活性天然产物在海洋生物体中含量低微,往往难以获取足够量的化合物进行后续药物的深入研究,成为海洋小分子药物研究的瓶颈之一。现代有机合成尤其是海洋天然产物全合成的迅猛发展,为获取复杂小分子海洋活性天然产物提供了1类重要手段。探究复杂小分子海洋天然产物合成的新策略和新方法,建立高效、高选择性的规模化制备技术,是国际海洋药物研究的热点。本文就6个上市的小分子海洋药物的全合成研究作一概述,重点阐述有机合成对于成药分子规模化制备的途径。 Marine derived natural products with novel skeleton and unique activity are important sources of leading compounds.However,it is difficult to collect marine samples and further the amount of high active compounds in marine organisms is usually scarce.These make it a challenge to obtain sufficient amount of compounds to conduct extensive druggability study.These problems become bottlenecks in small molecule marine drug research.The rapid development of modern organic synthesis,especially marine natural product total synthesis,provides an important approach to get access to complex small molecular marine bioactive natural products.Exploring new strategies and methods for complex small molecular or marine natural product synthesis and establishing efficient,highly selective and large-scale preparation technology have become a hot spot in world-wide marine drug research.In this perspective,we give an overview of the total synthesis of six small molecular marine drugs with the focus on the route of organic synthesis for large-scale preparation of products.
出处 《中国海洋药物》 CAS CSCD 2015年第6期95-108,共14页 Chinese Journal of Marine Drugs
基金 国家自然科学基金项目(21372208)资助
关键词 有机合成 海洋天然产物 全合成 海洋药物 organic synthesis marine nature product total synthesis marine drug
  • 相关文献

参考文献65

  • 1Newman D J, Cragg G M. Natural products as sources of new drugs over the 30 years from 1981 to 2010[J]. J ,Nat Prod, 2012, 75(3):311-335.
  • 2Kuttruff C A, Eastgate M D, Baran P S. Natural product synthesis in the age of Scalahility [J]. Nat Prod Rep, 2014, 31(4):419 432.
  • 3Bauer A, Br nstrup M. Industrial natural product chemistry for drug discovery and develowpment [J]. Nat Prod Rep, 2014, 31(1):35-60.
  • 4Mayer A M, Glaser K B, Cuevas C, et al. The odyssey of marine pharmaceuticals: a current pipeline perspective [J]. Trends Pharmacol Sci, 2010, 31(6) :255-265.
  • 5Absalon M J, Smith F (). Treatment strategies for pediatric acute myeloid leukemia [J]. E'pert ()pin Pharmacother, 2009, 10(1):57 79.
  • 6Thomas X. Chemotherapy of acute leukemia in adults [J]. Expert Opin Pharmacother, 2009, 10(2) :221 237.
  • 7Bazzanini R, Gouy M H, Peyrottes S, et al. Synthetic ap proaches to a mononucleotide prodrug of cytarabine [J]. Nucleosides Nucleotides Nucleic Acids, 2005, 24 (10-12) :1635 1649.
  • 8Tobias S C, Borch R F. Synthesis and biological evaluation of a cytarabine phosphoramidate prodrug[Jl. Mol Pharm, 2004, 1(2) : 112-116.
  • 9Gouy M H, Jordheim I. P, I.efebvre I, et al. Special fea ture of mixed phosphotriester derivati- ves of cylarabine [J]. BioorgMedChem, 2009, 17(17): 6340-6347.
  • 10Legoabe I. J, N'Da D D, Breytenbach J C, et al. Synthesis and transdermal permeation of novel N4-methoxypoly(eth ylene glycol) carbamates of cytarabine [J]. Drug Dev lnd Pharm, 2010, 36(12):1477-85.

二级参考文献11

  • 1渠桂荣,韩素辉,张志广,耿明伟,薛峰.5-溴嘧啶衍生物的微波绿色合成[J].河南师范大学学报(自然科学版),2006,34(2):65-67. 被引量:5
  • 2渠桂荣,张志广,夏然,耿明伟.微波辅助下5-碘尿嘧啶衍生物的绿色合成[J].河南师范大学学报(自然科学版),2007,35(2):101-103. 被引量:5
  • 3Diana G D, Pancic F. Chemotherapy of Virus Diseases[J]. Angew Chem Int Ed,1976,15(7) :410-416.
  • 4Reist E J, Bartuska V J, Goodman L. Sodium-Liquid Ammonia Debenzylations in Nucleoside Synthesis[J]. J Org Chem, 1964,29 (12) : 3725-3726.
  • 5Lee W W, Benitez A, Goodman L, et al. Potental Anticancer Agent: Synthesis of the β-Anomer of 9-(D-Arabinofuranosyl) Adenine[J]. J Am Chem Soc,1960,82(10):2648-2649.
  • 6Utagawa T, Morisawa H, Yamanaka S, et al. Microbial Synthesis of Purine Arabinosides and Their Biological Activity[J]. Agric Biol Chem,1985,49(7) :2167-2171.
  • 7Kaneko M, Kimura M, Nishimura T, et al. Synthesis of N^6 or 8-substituted 9-β-D-arabinofuranosyl-adenine and Their Antiviral Activities against Herpes Simplex and Vaccinia Viruses[J]. Chem Pharm Bull, 1977,25 (10) : 2482- 2489.
  • 8Utagawa T. Enzymatic Preparation of Nucleoside Antibiotics[J]. J Mol Cata B-Enzym, 1999,6 : 215- 222.
  • 9Ranganathan R. A Novel Purine Nucleoside Synthesis : 9-β-D-arabinofuranosyl adenine[J]. Tetrahedron Lett, 1975,16 (13) : 1185 - 1188.
  • 10Gedye R, Smith F, Westanay K, et al. The use of microwave ovens for rapid organic synthesis[J]. Tetrahedron Lett, 1986,27 (3):279- 282.

共引文献10

同被引文献145

引证文献6

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部